ImmunityBio, Inc.(IBRX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IBRX ImmunityBio, Inc.

已收盘 04-22 16:00:00 EDT

2.69

+0.18

+7.17%

盘后2.73

+0.04+1.49%

19:30 EDT

最高2.75	最低2.54	成交量617.31万
今开2.54	昨收2.51	日振幅8.37%
总市值22.96亿	流通市值5.51亿	总股本8.53亿
成交额1,649万	换手率3.01%	流通股本2.05亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"IBRX","market":"US","secType":"STK","nameCN":"ImmunityBio, Inc.","latestPrice":2.69,"timestamp":1745352000000,"preClose":2.51,"halted":0,"volume":6173131,"hourTrading":{"tag":"盘后","latestPrice":2.73,"preClose":2.69,"latestTime":"19:30 EDT","volume":42586,"amount":114840.8544,"timestamp":1745364620300},"delay":0,"floatShares":204853337,"shares":853442137,"eps":-0.618872,"marketStatus":"已收盘","change":0.18,"latestTime":"04-22 16:00:00 EDT","open":2.54,"high":2.75,"low":2.54,"amount":16485449.426787699,"amplitude":0.083665,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.618872,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1745395200000},"marketStatusCode":5,"adr":0,"listingDate":1438056000000,"exchange":"NASDAQ","adjPreClose":2.51,"preHourTrading":{"tag":"盘前","latestPrice":2.5401,"preClose":2.51,"latestTime":"09:27 EDT","volume":17329,"amount":43994.5428806,"timestamp":1745328464843},"postHourTrading":{"tag":"盘后","latestPrice":2.73,"preClose":2.69,"latestTime":"19:30 EDT","volume":42586,"amount":114840.8544,"timestamp":1745364620300},"volumeRatio":0.82263,"impliedVol":1.2243,"impliedVolPercentile":0.684},"requestUrl":"/m/hq/s/IBRX","defaultTab":"news","newsList":[{"id":"2529580312","title":"Immunitybio, Inc.盘中异动 早盘股价大涨5.38%报2.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529580312","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529580312?lang=zh_cn&edition=full","pubTime":"2025-04-22 22:01","pubTimestamp":1745330468,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日22时01分，Immunitybio, Inc.股票出现波动，股价急速上涨5.38%。截至发稿，该股报2.65美元/股，成交量90.3665万股，换手率0.10%，振幅3.98%。Immunitybio, Inc.股票所在的生物技术行业中，整体涨幅为1.23%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422220109a462915d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422220109a462915d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBRX","BK4139"],"gpt_icon":0},{"id":"2527724996","title":"Immunitybio, Inc.盘中异动 急速下跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527724996","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527724996?lang=zh_cn&edition=full","pubTime":"2025-04-16 21:54","pubTimestamp":1744811655,"startTime":"0","endTime":"0","summary":"北京时间2025年04月16日21时54分，Immunitybio, Inc.股票出现异动，股价急速下挫5.04%。Immunitybio, Inc.股票所在的生物技术行业中，整体跌幅为1.19%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041621541594d78886&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041621541594d78886&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBRX"],"gpt_icon":0},{"id":"2527164424","title":"Immunitybio, Inc.盘中异动 急速上涨6.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527164424","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527164424?lang=zh_cn&edition=full","pubTime":"2025-04-14 21:33","pubTimestamp":1744637591,"startTime":"0","endTime":"0","summary":"北京时间2025年04月14日21时33分，Immunitybio, Inc.股票出现波动，股价大幅上涨6.27%。Immunitybio, Inc.股票所在的生物技术行业中，整体涨幅为0.95%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414213312a4588f2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414213312a4588f2a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBRX","BK4139"],"gpt_icon":0},{"id":"2526618766","title":"Immunitybio, Inc.盘中异动 快速拉升5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526618766","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2526618766?lang=zh_cn&edition=full","pubTime":"2025-04-12 00:37","pubTimestamp":1744389433,"startTime":"0","endTime":"0","summary":"北京时间2025年04月12日00时37分，Immunitybio, Inc.股票出现异动，股价快速上涨5.08%。Immunitybio, Inc.股票所在的生物技术行业中，整体涨幅为1.14%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412003713a4565c87&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412003713a4565c87&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBRX"],"gpt_icon":0},{"id":"2518744703","title":"Immunitybio, Inc.2024财年实现净利润-4.14亿美元，同比增加28.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518744703","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518744703?lang=zh_cn&edition=full","pubTime":"2025-03-09 00:01","pubTimestamp":1741449675,"startTime":"0","endTime":"0","summary":"3月9日，Immunitybio, Inc.公布财报，公告显示公司2024财年净利润为-4.14亿美元，同比增加28.99%；其中营业收入为14.75百万美元，同比增加2271.38%，每股基本收益为-0.59美元。从资产负债表来看，Immunitybio, Inc.总负债8.71亿美元，其中短期债务8.71百万美元，资产负债比为0.44，流动比率为0.04。机构评级：截至2025年3月9日，当前有5家机构对Immunitybio, Inc.目标价做出预测，其中目标均价为11.25美元，其中最低目标价为4.25美元，最高目标价为30.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000245abef9883&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000245abef9883&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBRX"],"gpt_icon":0},{"id":"2516313637","title":"Immunitybio, Inc.盘中异动 早盘急速下跌5.47%报3.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516313637","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516313637?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:31","pubTimestamp":1741012286,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时31分，Immunitybio, Inc.股票出现异动，股价急速跳水5.47%。截至发稿，该股报3.11美元/股，成交量52.7219万股，换手率0.07%，振幅3.95%。Immunitybio, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223126abe632ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223126abe632ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBRX"],"gpt_icon":0},{"id":"1176337306","title":"ImmunityBio 2024年第四季度GAAP每股收益$(0.09)优于预期$(0.20)，销售额$7.55M不及预期$7.82M，拥有$149.8M现金及现金等价物和有价证券","url":"https://stock-news.laohu8.com/highlight/detail?id=1176337306","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176337306?lang=zh_cn&edition=full","pubTime":"2025-03-03 20:40","pubTimestamp":1741005640,"startTime":"0","endTime":"0","summary":"ImmunityBio报告季度每股亏损为$，优于分析师共识预期的$，高出55%。相比去年同期每股亏损$，这是一个74.29%的增长。公司报告季度销售额为755万美元，低于分析师共识预期的782万美元，低了3.39%。以上内容来自Benzinga Earnings专栏，原文如下：ImmunityBio  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 55 percent. This is a 74.29 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $7.55 million which missed the analyst consensus estimate of $7.82 million by 3.39 percent.  This is a 5.33K per","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"ImmunityBio 2024年第四季度GAAP每股收益$(0.09)优于预期$(0.20)，销售额$7.55M不及预期$7.82M，拥有$149.8M现金及现金等价物和有价证券","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRX"],"gpt_icon":1},{"id":"2514320750","title":"Immunitybio, Inc.盘中异动 早盘急速拉升8.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514320750","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514320750?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:32","pubTimestamp":1740753156,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时32分，Immunitybio, Inc.股票出现波动，股价快速拉升8.22%。Immunitybio, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223236a2580178&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223236a2580178&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBRX","BK4139"],"gpt_icon":1},{"id":"2514330344","title":"Immunitybio, Inc.盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514330344","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514330344?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:52","pubTimestamp":1740689569,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时52分，Immunitybio, Inc.股票出现异动，股价大幅下挫5.00%。Immunitybio, Inc.股票所在的生物技术行业中，整体跌幅为0.51%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280452499632f5f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280452499632f5f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBRX"],"gpt_icon":0},{"id":"2514018034","title":"Immunitybio, Inc.盘中异动 急速跳水5.28%报3.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514018034","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514018034?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:01","pubTimestamp":1740495689,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时01分，Immunitybio, Inc.股票出现异动，股价大幅跳水5.28%。Immunitybio, Inc.股票所在的生物技术行业中，整体涨幅为0.95%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225230129a2538e75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225230129a2538e75&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBRX"],"gpt_icon":0},{"id":"2514773049","title":"Immunitybio, Inc.盘中异动 早盘急速下跌5.26%报3.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514773049","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514773049?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:38","pubTimestamp":1740411517,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时38分，Immunitybio, Inc.股票出现波动，股价快速下挫5.26%。Immunitybio, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224233838989105bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224233838989105bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBRX"],"gpt_icon":0},{"id":"2513157382","title":"Immunitybio, Inc.盘中异动 下午盘大幅下挫5.07%报3.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513157382","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513157382?lang=zh_cn&edition=full","pubTime":"2025-02-22 02:21","pubTimestamp":1740162070,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日02时21分，Immunitybio, Inc.股票出现异动，股价急速下挫5.07%。截至发稿，该股报3.46美元/股，成交量285.612万股，换手率0.39%，振幅7.97%。Immunitybio, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222022111abd7e044&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222022111abd7e044&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBRX"],"gpt_icon":0},{"id":"2512838624","title":"Immunitybio, Inc.盘中异动 早盘股价大涨5.07%报3.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512838624","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512838624?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:39","pubTimestamp":1739975954,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时39分，Immunitybio, Inc.股票出现波动，股价急速上涨5.07%。截至发稿，该股报3.52美元/股，成交量43.3085万股，换手率0.06%，振幅3.84%。Immunitybio, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502192239149628cebe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502192239149628cebe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBRX"],"gpt_icon":0},{"id":"2512196837","title":"Immunitybio, Inc.盘中异动 下午盘股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512196837","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512196837?lang=zh_cn&edition=full","pubTime":"2025-02-19 02:55","pubTimestamp":1739904935,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日02时55分，Immunitybio, Inc.股票出现波动，股价大幅下跌5.11%。Immunitybio, Inc.股票所在的生物技术行业中，整体涨幅为0.43%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219025535a24ae3b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219025535a24ae3b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBRX"],"gpt_icon":0},{"id":"2511069628","title":"Immunitybio, Inc.盘中异动 股价大涨5.12%报3.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511069628","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511069628?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:33","pubTimestamp":1739543593,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时33分，Immunitybio, Inc.股票出现异动，股价大幅上涨5.12%。截至发稿，该股报3.49美元/股，成交量25.0113万股，换手率0.03%，振幅2.68%。Immunitybio, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422331396231bae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422331396231bae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBRX"],"gpt_icon":0},{"id":"2510339340","title":"Immunitybio, Inc.盘中异动 早盘急速下挫5.01%报3.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510339340","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510339340?lang=zh_cn&edition=full","pubTime":"2025-02-11 23:54","pubTimestamp":1739289266,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日23时54分，Immunitybio, Inc.股票出现波动，股价快速跳水5.01%。Immunitybio, Inc.股票所在的生物技术行业中，整体跌幅为1.77%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112354269881cc38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112354269881cc38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCEA","BK4139","IBRX"],"gpt_icon":0},{"id":"2508491191","title":"Immunitybio, Inc.盘中异动 快速下挫5.51%报3.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508491191","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508491191?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:33","pubTimestamp":1738593184,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时33分，Immunitybio, Inc.股票出现波动，股价大幅跳水5.51%。Immunitybio, Inc.股票所在的生物技术行业中，整体跌幅为0.43%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223304abc10738&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203223304abc10738&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBRX","BK4139"],"gpt_icon":0},{"id":"2508993019","title":"Immunitybio, Inc.盘中异动 股价大涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508993019","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508993019?lang=zh_cn&edition=full","pubTime":"2025-02-01 01:50","pubTimestamp":1738345848,"startTime":"0","endTime":"0","summary":"北京时间2025年02月01日01时50分，Immunitybio, Inc.股票出现波动，股价快速拉升5.19%。Immunitybio, Inc.股票所在的生物技术行业中，整体涨幅为1.91%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201015048a23564d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201015048a23564d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBRX","BK4139"],"gpt_icon":0},{"id":"2507862069","title":"Immunitybio, Inc.盘中异动 早盘股价大涨5.22%报3.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507862069","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507862069?lang=zh_cn&edition=full","pubTime":"2025-01-30 23:51","pubTimestamp":1738252276,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日23时51分，Immunitybio, Inc.股票出现异动，股价大幅上涨5.22%。截至发稿，该股报3.33美元/股，成交量194.743万股，换手率0.27%，振幅7.44%。Immunitybio, Inc.股票所在的生物技术行业中，整体跌幅为0.24%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130235116961446b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250130235116961446b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBRX","BK4139"],"gpt_icon":0},{"id":"2507316416","title":"Immunitybio, Inc.盘中异动 快速拉升5.19%报3.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507316416","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507316416?lang=zh_cn&edition=full","pubTime":"2025-01-29 22:31","pubTimestamp":1738161064,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日22时31分，Immunitybio, Inc.股票出现异动，股价快速上涨5.19%。Immunitybio, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Immunitybio, Inc.公司简介：ImmunityBio Inc 是一家临床阶段的综合性生物技术公司，致力于发现，开发和商业化下一代免疫和细胞疗法，以增强天然免疫系统，驱动和维持免疫反应。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129223104987609f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250129223104987609f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBRX"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.immunitybio.com","stockEarnings":[{"period":"1week","weight":-0.1315},{"period":"1month","weight":-0.0738},{"period":"3month","weight":-0.2205},{"period":"6month","weight":-0.2746},{"period":"1year","weight":-0.5237},{"period":"ytd","weight":-0.0195}],"compareEarnings":[{"period":"1week","weight":-0.0468},{"period":"1month","weight":-0.0888},{"period":"3month","weight":-0.1479},{"period":"6month","weight":-0.1109},{"period":"1year","weight":0.0378},{"period":"ytd","weight":-0.1232}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ImmunityBio, Inc.于2002年10月7日在伊利诺伊州ZelleRx Corporation公司的名义下注册成立，于2010年1月22日，公司更名为Conkwest股份有限公司。ImmunityBio是一家领先的晚期免疫治疗公司，可激活先天和适应性免疫系统，以治疗肿瘤学和传染病领域内严重未满足的需求。公司是一家领先的临床剂型的现成自然杀伤细胞疗法生产商，记忆NK细胞，连同抗体细胞因子融合蛋白、白蛋白结合化学免疫调节剂和疫苗载体的综合平台。通过结合这些NK、巨噬细胞和T细胞激活平台，该公司相信ImmunityBio在免疫治疗领域处于领先地位，具有跨越多种肿瘤类型和传染病的后期临床开发。","yearOnYearQuotes":[{"month":1,"riseRate":0.3,"avgChangeRate":0.02541},{"month":2,"riseRate":0.5,"avgChangeRate":0.026818},{"month":3,"riseRate":0.3,"avgChangeRate":-0.083879},{"month":4,"riseRate":0.5,"avgChangeRate":0.021643},{"month":5,"riseRate":0.333333,"avgChangeRate":0.053418},{"month":6,"riseRate":0.333333,"avgChangeRate":0.147898},{"month":7,"riseRate":0.444444,"avgChangeRate":-0.024912},{"month":8,"riseRate":0.3,"avgChangeRate":-0.116269},{"month":9,"riseRate":0.3,"avgChangeRate":-0.041956},{"month":10,"riseRate":0.5,"avgChangeRate":0.035321},{"month":11,"riseRate":0.7,"avgChangeRate":0.13572},{"month":12,"riseRate":0.4,"avgChangeRate":0.069947}],"exchange":"NASDAQ","name":"ImmunityBio, Inc.","nameEN":"ImmunityBio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ImmunityBio, Inc.(IBRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ImmunityBio, Inc.(IBRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ImmunityBio, Inc.,IBRX,ImmunityBio, Inc.股票,ImmunityBio, Inc.股票老虎,ImmunityBio, Inc.股票老虎国际,ImmunityBio, Inc.行情,ImmunityBio, Inc.股票行情,ImmunityBio, Inc.股价,ImmunityBio, Inc.股市,ImmunityBio, Inc.股票价格,ImmunityBio, Inc.股票交易,ImmunityBio, Inc.股票购买,ImmunityBio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ImmunityBio, Inc.(IBRX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ImmunityBio, Inc.(IBRX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}